Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Merck's top dealmaker signals more M&A as Keytruda's patent cliff nears

Merck CEO Robert Davis has been landing deals “with urgency” over the last few years in an effort to shore up the pipeline ahead of Keytruda’s upcoming patent cliff. But make no mistake: The company ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Thursday 3 September →